Analysis of MDR in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-2020.
Heather J AdamJames A KarlowskyMelanie R BaxterJohn SchellenbergAlyssa R GoldenIrene MartinWalter DemczukMichael R MulveyGeorge G ZhanelPublished in: The Journal of antimicrobial chemotherapy (2023)
Although current vaccine coverage of MDR S. pneumoniae in Canada is high, the increasing diversity of serotypes observed among the MDR isolates highlights the ability of S. pneumoniae to rapidly evolve.
Keyphrases